CN106138482A - A kind of herb formulation treating nasal mucosa inflammation - Google Patents
A kind of herb formulation treating nasal mucosa inflammation Download PDFInfo
- Publication number
- CN106138482A CN106138482A CN201610644058.9A CN201610644058A CN106138482A CN 106138482 A CN106138482 A CN 106138482A CN 201610644058 A CN201610644058 A CN 201610644058A CN 106138482 A CN106138482 A CN 106138482A
- Authority
- CN
- China
- Prior art keywords
- herb
- herba
- nasal mucosa
- herb formulation
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of herb formulation treating nasal mucosa inflammation, herb formulation includes Herba Cayatiae Japonicae 0.13 0.6 parts, Climbing Viloet Herb 0.2 1.0 parts, Herba Plantaginis 0.08 0.45 parts, Herba Bidentis Bipinnatae 0.2 0.6 parts, mountain Huang Cape jasmine 0.2 0.4 parts, Herba Commelinae 0.1 0.7 parts, Folium Perillae 0.08 0.4 parts, the present invention can thoroughly treat rhinitis, it is difficult to recurrence, people will not have dependency to medicine, and little to people's side effect.
Description
Technical field
The present invention relates to the field of Chinese medicine formula, especially relate to a kind of herb formulation treating nasal mucosa inflammation.
Background technology
Rhinitis is the chronic inflammatory disease of nasal mucosa and Submucosa.It is mainly characterized by inflammation and continues more than three months or repeatedly
Outbreak, protracted course of disease, the intermission also can not recover normal, and without clear and definite pathogenic microorganism, with nasal obstruction in various degree, point
Secretions, tunica mucosa nasi swelling or the obstacle such as thicken.Pathology according to chronic rhinitis and the degree of dysfunction, can be divided into chronic
Simple rhinitis and chronic hypertrophic rhinitis, the former is the nasal mucosa chronic inflammation being characterized with tunica mucosa nasi swelling, secretions increase
Disease, the latter is with the plump nasal cavity chronic inflammatory disease as feature of mucosa, the Submucosa even limitation of sclerotin or diffusivity hypertrophy.
The medicine of existing treatment rhinitis, can only respite rhinitis, easily recur, and can not thoroughly effect a radical cure rhinitis, and to medicine
There is dependency, but also people is had the biggest side effect.
Summary of the invention
It is an object of the invention to the deficiency overcoming prior art to exist, it is provided that a kind of can thoroughly effect a radical cure nasal mucosa inflammation
Herb formulation.
For achieving the above object, the present invention provides following technical scheme: a kind of herb formulation treating nasal mucosa inflammation, presses
Weight portion, herb formulation includes Herba Cayatiae Japonicae 0.13-0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis 0.08-0.45 part.
By weight, described herb formulation also includes mountain Huang Cape jasmine 0.2-0.4 part.
By weight, described herb formulation also includes Herba Bidentis Bipinnatae 0.2-0.6 part.
By weight, described herb formulation also includes Herba Commelinae 0.1-0.7 part.
By weight, described herb formulation also includes Folium Perillae 0.08-0.4 part.
Preferably, by weight, described Herba Cayatiae Japonicae 0.5 part, Climbing Viloet Herb 0.45 part, Herba Plantaginis 0.3 part.
Preferably, by weight, described Herba Bidentis Bipinnatae is 0.35 part.
Preferably, by weight, described mountain Huang Cape jasmine is 0.3 part.
Preferably, by weight, described Herba Commelinae is 0.5 part.
Preferably, by weight, described Folium Perillae is 0.4 part.
Compared with prior art, the invention has the beneficial effects as follows: the present invention can thoroughly treat rhinitis, be difficult to recurrence, people
Medicine will not be had dependency, and little to people's side effect, antiinflammatory toxin expelling of the present invention, relieving cough and resolving phlegm, damp eliminating trembles with fear, work of stimulating the menstrual flow
Blood, has significant curative effect to chronic rhinitis, allergic rhinitis, sinusitis etc..
Detailed description of the invention
Below the technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment
It is only a part of embodiment of the present invention rather than whole embodiments.Based on the embodiment in the present invention, the common skill in this area
The every other embodiment that art personnel are obtained under not making creative work premise, broadly falls into the model of present invention protection
Enclose.
Embodiment 1: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes Herba Cayatiae Japonicae 0.13-
0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis 0.08-0.45 part..
Case: man, 15 one full year of life, suffers from allergic rhinitis, frequent runny nose, and one to spring, season, nose was difficult to be subject to, and made
With inventive formulation two months, effect was notable.
Embodiment 2: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes Herba Cayatiae Japonicae 0.13-
0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis 0.08-0.45 part, mountain Huang Cape jasmine 0.2-0.4 part.
Case: female 57 one full year of life, suffer from chronic rhinitis, always sensation nose is the most stifled, the most also flows the nasal mucus of cyan, seriously
When also can headache impact sleep, use inventive formulation two months, symptom has taken a turn for the better.
Embodiment 3: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes Herba Cayatiae Japonicae 0.13-
0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis: 0.08-0.45 part, mountain Huang Cape jasmine 0.2-0.4 part, Herba Bidentis Bipinnatae 0.2-0.6 part.
Case: female, 45 one full year of life, suffers from chronic rhinitis, frequent sneeze, rhinorrhea, and nasal obstruction is serious, breathes in bed not
Freely, using inventive formulation two months, effect is notable.
Embodiment 4: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes Herba Cayatiae Japonicae 0.13-
0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis 0.08-0.45 part, mountain Huang Cape jasmine 0.2-0.4 part, Herba Bidentis Bipinnatae 0.2-0.6 part, the duck sole of the foot
Grass 0.1-0.7 part.
Case: female, 46 one full year of life, suffers from chronic rhinitis, frequent rhinorrhea, and nasal obstruction occasional is itched, and hypopnea is sometimes
Needing, by face assisted respiartion, to use inventive formulation two months, symptom has been alleviated, and breathes smooth and easy.
Embodiment 5: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes Herba Cayatiae Japonicae 0.13-
0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis 0.08-0.45 part, mountain Huang Cape jasmine 0.2-0.4 part, Herba Bidentis Bipinnatae 0.2-0.6 part, the duck sole of the foot
Grass 0.1-0.7 part, Folium Perillae 0.08-0.4 part.
Case: female, 54 one full year of life, suffers from allergic rhinitis, and at ordinary times with regard to frequent sneeze, nose can be itched and clear water nasal mucus is many,
Especially when the early spring, spring and summer replace, sneeze also can cause the rubescent phenomenon itched and shed tears of eyes, hypopnea and rhinophonia
Seriously, using inventive formulation two wheat harvesting period, rhinitis situation is preferably improved, and speaks and does not substantially have rhinophonia, and effect is notable.
Embodiment 6: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is 0.5
Part, Climbing Viloet Herb 0.45 part, Herba Plantaginis 0.3 part.
Case: man, 7 one full year of life, suffers from allergic rhinitis, and sneeze of getting up every day is continuous, often has a stuffy nose, nasal mucus be yellow green and
Thickness.During 9-10 month in 2015, adhere to that every other day medication is stifling once, adhere to ten times.Symptom is obviously improved, nasal mucus
It is the most watery that color is become light color from yellow green, and sneeze reduces, and nasal obstruction alleviates, after to change medication weekly into stifling once, adhere to one
Month, Rhinitis Symptoms is inconspicuous, and times of common cold reduces.
Embodiment 7: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is
0.5 part, Climbing Viloet Herb 0.45 part, Herba Plantaginis 0.3 part, Herba Bidentis Bipinnatae is 0.35 part.
Case: female, 9 one full year of life, suffers from severe sinus scorching, feel not sleep well every night, and dyspnea is often had a stuffy nose, nasal mucus
Major part is yellow green.During 3-4 month in 2016, starting medication every day and fumigate once, adhere to ten days, symptom substantially changes
Kind, nasal obstruction alleviates, and sleep is the best；It is that every other day medication is stifling once afterwards, changed into later weekly, and adhered to two
Month, Rhinitis Symptoms is inconspicuous, still adheres to continuing medication.
Embodiment 8: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is 0.5
Part, Climbing Viloet Herb 0.45 part, Herba Plantaginis 0.3 part, Herba Bidentis Bipinnatae are 0.35 part, mountain Huang Cape jasmine is 0.3 part.
Case: female, 10 one full year of life, suffers from allergic rhinitis, and nasal mucus is continuous, and often nasal obstruction is not sleep well.Open in March, 2016
Beginning, adhere to that medication every day is stifling and once adhere to one week, symptom is obviously improved.After every other day medication stifling once, adhere to one
Month, effect is notable.
Embodiment 9: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is 0.5
Part, Climbing Viloet Herb 0.45 part, Herba Plantaginis 0.3 part, Herba Bidentis Bipinnatae are 0.35 part, mountain Huang Cape jasmine is 0.3 part, Herba Commelinae is 0.5 part.
Case: female, 15 one full year of life, suffers from allergic rhinitis.Also have symptom snotty when of flu, see doctor
Western medicine was used in life, and curative effect is inconspicuous.In March, 2016, medication every day is stifling once to be adhered to 20 days, and effect is notable.
Embodiment 10: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is
0.5 part, Climbing Viloet Herb 0.45 part, Herba Plantaginis 0.3 part, Herba Bidentis Bipinnatae be 0.35 part, mountain Huang Cape jasmine be 0.3 part, Herba Commelinae be 0.5 part, purple
Soviet Union is 0.4 part.
Case: female, 61 one full year of life, the rhinophonia that band always of speaking is the most serious, nasal mucus is continuous, often has a stuffy nose, impact sleep.?
During 5-6 months in 2015, starting medication every day and fumigate once, adhere to ten days, symptom is obviously improved, and nasal obstruction alleviates, and nasal mucus subtracts
Few；Being that every other day medication is stifling afterwards once to change into later weekly, and adhered to two months, Rhinitis Symptoms is inconspicuous, says
Words are not through the nose, and articulation and clear, sleep quality is greatly improved.
Embodiment 11: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is
0.13 part, Climbing Viloet Herb 0.2 part, Herba Plantaginis 0.08 part, Herba Bidentis Bipinnatae be 0.2 part, mountain Huang Cape jasmine be 0.2 part, Herba Commelinae be 0.1 part, purple
Soviet Union is 0.08 part.
Case: man, 18 one full year of life, every day, nose was uncomfortable, often had a stuffy nose, impact sleep, during 1-2 month in 2016,
Medication every day is stifling once to be adhered to 20 days, and symptom is obviously improved, and speaks and is not through the nose, articulation and clear, and sleep quality has very
Big improvement.
Embodiment 12: a kind of herb formulation treating nasal mucosa inflammation, by weight, herb formulation includes that Herba Cayatiae Japonicae is
0.6 part, Climbing Viloet Herb 1 part, Herba Plantaginis 0.45 part, Herba Bidentis Bipinnatae be 0.6 part, mountain Huang Cape jasmine be 0.4 part, Herba Commelinae be 0.7 part, Folium Perillae be
0.4 part.
Case: female, 28 one full year of life, often has a stuffy nose every day, impact sleep, during 6-12 month in 2016, every day medicine-smoking
Steaming once, adhere to 60 days, symptom is obviously improved, and nasal obstruction is obviously improved, and sleep quality is greatly improved.
Effect principle of the present invention:
Herba Cayatiae Japonicae effect: cold in nature, leaf heat-clearing and toxic substances removing, root removing heat from blood is subsided a swelling.Climbing Viloet Herb effect: cold in nature, removing heat from the lung and dissipating phlegm, evacuation of pus disappears
Swollen.Herba Plantaginis effect: cold in nature, clearing away heat and promoting diuresis, relieving cough and resolving phlegm, sub-liver heat removing and eyesight improving, relieving stranguria by diuresis.Herba Bidentis Bipinnatae effect: property is put down, heat clearing away
Removing toxic substances, qi-restoratives antidiarrheal.Mountain Huang Cape jasmine: effect is cold in nature, clearing away heat-fire, relieving restlessness, cooling blood for hemostasis.Folium Perillae effect: warm in nature, leaf induces sweat scattered
Cold, relieving QI stagnancy in the stomach, solving toxin of fish and crab；Stalk regulating QI is antiabortive；Sub-therapeutic method to keep the adverse QI flowing downwards expectorant.Herba Commelinae effect: cold in nature, heat-clearing and toxic substances removing.Therefore this
Bright have antiinflammatory toxin expelling, relieving cough and resolving phlegm, and damp eliminating is trembled with fear, restored menstrual flow and invigorated blood circulation, have chronic rhinitis, allergic rhinitis, sinusitis etc. significantly
Curative effect.The present invention can thoroughly treat rhinitis, is difficult to recurrence, and people will not have dependency to medicine, and to people's side effect
Little.
Although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, permissible
Understand and these embodiments can be carried out multiple change without departing from the principles and spirit of the present invention, revise, replace
And modification, the scope of the present invention be defined by the appended.
Claims (10)
1. the herb formulation treating nasal mucosa inflammation, it is characterised in that: by weight, described herb formulation includes Herba Cayatiae Japonicae
0.13-0.6 part, Climbing Viloet Herb 0.2-1.0 part, Herba Plantaginis 0.08-0.45 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 1, it is characterised in that: by weight, institute
State herb formulation and also include mountain Huang Cape jasmine 0.2-0.4 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 1, it is characterised in that: by weight, institute
State herb formulation and also include Herba Bidentis Bipinnatae 0.2-0.6 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 1, it is characterised in that: by weight, institute
State herb formulation and also include Herba Commelinae 0.1-0.7 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 1, it is characterised in that: by weight, institute
State herb formulation and also include Folium Perillae 0.08-0.4 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 1, it is characterised in that: by weight, institute
State Herba Cayatiae Japonicae 0.5 part, Climbing Viloet Herb 0.45 part, Herba Plantaginis are 0.3 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 3, it is characterised in that: by weight, institute
Stating Herba Bidentis Bipinnatae is 0.35 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 2, it is characterised in that: by weight, institute
Stating mountain Huang Cape jasmine is 0.3 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 4, it is characterised in that: by weight, institute
Stating Herba Commelinae is 0.5 part.
A kind of herb formulation treating nasal mucosa inflammation the most according to claim 5, it is characterised in that: by weight, institute
Stating Folium Perillae is 0.4 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610644058.9A CN106138482A (en) | 2016-08-05 | 2016-08-05 | A kind of herb formulation treating nasal mucosa inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610644058.9A CN106138482A (en) | 2016-08-05 | 2016-08-05 | A kind of herb formulation treating nasal mucosa inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106138482A true CN106138482A (en) | 2016-11-23 |
Family
ID=57328695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610644058.9A Pending CN106138482A (en) | 2016-08-05 | 2016-08-05 | A kind of herb formulation treating nasal mucosa inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106138482A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114796453A (en) * | 2022-02-25 | 2022-07-29 | 中科梅奥(杭州)生物工程有限公司 | Method for applying BMAP (BMAP) derived peptide to respiratory system cough antiphlogosis |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1569094A (en) * | 2003-07-22 | 2005-01-26 | 刘智勇 | Nasosinusitis treating medicinal pills |
| CN1671404A (en) * | 2002-04-22 | 2005-09-21 | 松浦药业株式会社 | Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| CN102784252A (en) * | 2012-08-01 | 2012-11-21 | 林红丽 | Chinese medicine composition for treating nasosinusitis |
| CN102813761A (en) * | 2012-07-06 | 2012-12-12 | 李承平 | Fire-purging and heat-clearing tablets |
| CN102872279A (en) * | 2012-08-26 | 2013-01-16 | 李承平 | Tablets for clearing away lower energizer and dampness-heat |
| CN103638360A (en) * | 2013-12-11 | 2014-03-19 | 青岛中科菲力工程技术研发有限公司 | Chinese medicine powder for treating nasosinusitis |
| CN103830564A (en) * | 2014-03-10 | 2014-06-04 | 宁波大学 | Oral medicine for treating chronic nasosinusitis |
| CN105250485A (en) * | 2015-11-30 | 2016-01-20 | 谭新锋 | Medicine for treating allergic rhinitis |
| CN105477297A (en) * | 2015-12-22 | 2016-04-13 | 姜新帅 | Traditional Chinese medicine composition for treating nasosinusitis |
-
2016
- 2016-08-05 CN CN201610644058.9A patent/CN106138482A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1671404A (en) * | 2002-04-22 | 2005-09-21 | 松浦药业株式会社 | Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| CN1569094A (en) * | 2003-07-22 | 2005-01-26 | 刘智勇 | Nasosinusitis treating medicinal pills |
| CN102813761A (en) * | 2012-07-06 | 2012-12-12 | 李承平 | Fire-purging and heat-clearing tablets |
| CN102784252A (en) * | 2012-08-01 | 2012-11-21 | 林红丽 | Chinese medicine composition for treating nasosinusitis |
| CN102872279A (en) * | 2012-08-26 | 2013-01-16 | 李承平 | Tablets for clearing away lower energizer and dampness-heat |
| CN103638360A (en) * | 2013-12-11 | 2014-03-19 | 青岛中科菲力工程技术研发有限公司 | Chinese medicine powder for treating nasosinusitis |
| CN103830564A (en) * | 2014-03-10 | 2014-06-04 | 宁波大学 | Oral medicine for treating chronic nasosinusitis |
| CN105250485A (en) * | 2015-11-30 | 2016-01-20 | 谭新锋 | Medicine for treating allergic rhinitis |
| CN105477297A (en) * | 2015-12-22 | 2016-04-13 | 姜新帅 | Traditional Chinese medicine composition for treating nasosinusitis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114796453A (en) * | 2022-02-25 | 2022-07-29 | 中科梅奥(杭州)生物工程有限公司 | Method for applying BMAP (BMAP) derived peptide to respiratory system cough antiphlogosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103110706B (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN107648446A (en) | A kind of Chinese medicine preparation for treating exogenous cough and preparation method thereof | |
| CN106138482A (en) | A kind of herb formulation treating nasal mucosa inflammation | |
| CN104152304A (en) | Traditional Chinese medicine soap | |
| CN103623267A (en) | Medication for treating allergic rhinitis | |
| CN104474142B (en) | A kind of external medicine composition for treating rhinitis | |
| CN107669807A (en) | It is a kind of to be used to treat Chinese medicine preparation of eye disease alleviation ophthalmic uncomfortable and preparation method thereof | |
| CN103705680B (en) | A kind of Chinese medicine composition for the treatment of rhinitis and preparation method thereof | |
| CN106728970A (en) | It is a kind of to treat soft tissue injury and various arthroncus, the Traditional Chinese medicinal liquor of pain | |
| CN103908589B (en) | Plaster for treating cold | |
| CN110721303A (en) | Traditional Chinese medicine composition for treating allergic rhinitis and application thereof | |
| CN104491562A (en) | Traditional Chinese medicine composition used for treating conjunctivitis | |
| CN103599183A (en) | Chinese and western medicine composition for treating anaphylactic rhinitis | |
| CN104258095A (en) | Traditional Chinese medicine composition for treating hot cold | |
| CN111110817A (en) | Traditional Chinese medicine composition for treating eye diseases, preparation method and application thereof | |
| CN105106694B (en) | Treat the Chinese medicine preparation of rhinitis | |
| CN102698073A (en) | Traditional Chinese medicine extract for treating allergic rhinitis | |
| CN104606346A (en) | Chinese herbal medicine pill for treating spring catarrh conjunctivitis | |
| CN1679773A (en) | Eye-washing and vision-improving liquid | |
| CN104306949A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN104622990B (en) | It is a kind of to be used to treat Chinese medicine composition of rhinitis chronic and its preparation method and application | |
| CN107349320A (en) | Treat the chinese-western medicine preparation of rhinitis | |
| CN108578604A (en) | It is a kind of to treat dermopathic Chinese medicine composition and preparation method | |
| KR20050113098A (en) | Manufacturing method of anti-nicotine and antiviral mask, antibacterial panties, and antibacterial socks using Chinese herbal extract fermented cloth | |
| CN102772601A (en) | External medicine for treating facial paralysis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161123 |